These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 8974087

  • 1. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
    Fujikura N, Yokoyama T, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
    [Abstract] [Full Text] [Related]

  • 2. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
    Fujikura N, Yokoyama T, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
    Higashino R, Sato R, Jin H, Inoue N, Fukuta Y, Kurimoto T, Tamaki H.
    J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205
    [Abstract] [Full Text] [Related]

  • 4. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
    Yokoyama T, Fujikura N, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
    [Abstract] [Full Text] [Related]

  • 5. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
    Yokoyama T, Ichihara K, Abiko Y.
    Fundam Clin Pharmacol; 1997 Dec; 11(3):245-51. PubMed ID: 9243256
    [Abstract] [Full Text] [Related]

  • 6. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
    Jin H, Sato R, Higashino R, Fukuda Y, Kurimoto T, Tamaki H.
    Biol Pharm Bull; 1997 Feb; 20(2):196-200. PubMed ID: 9057986
    [Abstract] [Full Text] [Related]

  • 7. Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs.
    Yokoyama T, Ichihara K, Abiko Y.
    Jpn J Pharmacol; 1996 Dec; 72(4):291-7. PubMed ID: 9015737
    [Abstract] [Full Text] [Related]

  • 8. [Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].
    Ito S, Higashino R, Tanaka T, Takei M, Kurimoto T, Matsuda K.
    Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):263-70. PubMed ID: 8537073
    [Abstract] [Full Text] [Related]

  • 9. Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygen tension, and electrical abnormalities during acute coronary artery occlusion in dogs.
    Hashimoto H, Asano M, Takiguchi Y, Katoh H, Nakashima M.
    J Cardiovasc Pharmacol; 1985 Oct; 7(4):613-21. PubMed ID: 2410698
    [Abstract] [Full Text] [Related]

  • 10. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
    Chibana T, Noguchi K, Ojiri Y, Sakanashi M.
    Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752
    [Abstract] [Full Text] [Related]

  • 11. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart.
    Pijl AJ, Pfaffendorf M, van Zwieten PA.
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
    Masumiya H, Shijuku T, Tanaka H, Shigenobu K.
    Eur J Pharmacol; 1998 May 22; 349(2-3):351-7. PubMed ID: 9671117
    [Abstract] [Full Text] [Related]

  • 14. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ, Hartog JM, Hugenholtz PG, Saxena PR, Verdouw PD.
    Br J Pharmacol; 1986 May 22; 88(1):9-18. PubMed ID: 2871886
    [Abstract] [Full Text] [Related]

  • 15. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Ozawa Y, Saruta T.
    Clin Sci (Lond); 2001 Oct 22; 101(4):421-7. PubMed ID: 11566080
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M, Noguchi K, Miyamoto Y, Kato T, Nagamine F, Yu WY, Higuchi M, Nakasone J.
    Arch Int Pharmacodyn Ther; 1988 Oct 22; 294():159-74. PubMed ID: 2976588
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of FR 34235, a new slow channel calcium blocker, and nifedipine on hemodynamics and myocardial oxygen consumption in the anesthetized dog.
    Gross GJ, Warltier DC, Hardman HF.
    Gen Pharmacol; 1983 Oct 22; 14(6):677-80. PubMed ID: 6662348
    [Abstract] [Full Text] [Related]

  • 18. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
    Tanaka H, Masumiya H, Sekine T, Sijuku T, Sugahara M, Taniguchi H, Terada M, Saito W, Shigenobu K.
    Gen Pharmacol; 1996 Apr 22; 27(3):451-4. PubMed ID: 8723524
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S.
    Circ J; 2003 Feb 22; 67(2):139-45. PubMed ID: 12547996
    [Abstract] [Full Text] [Related]

  • 20. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T.
    J Hypertens; 2001 Nov 22; 19(11):2031-7. PubMed ID: 11677369
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.